NCT04404738

MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology

Clinical Studies of Robotic-assisted Surgery in Urology With MicroPort® Endoscopic Instrument Control System

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 104 (estimated)
• Sponsor: Changhai Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Laparoscopy, now virtually completely, was replaced with robotic surgery in uro-oncological surgery in the world. And given the significant increase in the number of robotic surgeries for prostate, bladder and kidney cancer, it is now a major domain in oncological surgery. Microport MedBot Inc. has independently developed a domestic surgical robot in China. Therefore, the purpose of the study is to evaluate the safety and efficacy of the Chinese robot when applied to surgery in oncology.

Conditions

• Robotic Surgical Procedures
• Prostatectomy
• Nephrectomy

Interventions

Type	Name	Description
PROCEDURE	MicroPort® robot-assisted laparoscopic surgery	In this group, patients undergoing robot-assisted laparoscopic surgery in urology will be performed by Microport® Surgical System
PROCEDURE	da Vinci robot-assisted laparoscopic surgery	In this group, patients undergoing robot-assisted laparoscopic surgery in urology will be performed by da Vinci Surgical System

Timeline

• Start date: 2020-06-29
• Primary completion: 2022-09-01
• Completion: 2022-12-01
• First posted: 2020-05-27
• Last updated: 2020-09-01

Locations

4 sites across 1 country: China